Cargando…

Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients

The exploration of accurate diagnostic markers for differential diagnosis of neurodegenerative diseases is an ongoing topic. A previous study on cerebrospinal fluid (CSF)-mitochondrial malate dehydrogenase 1 (MDH1) in sporadic Creutzfeldt–Jakob disease (sCJD) patients revealed a highly significant u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zerr, Inga, Villar-Piqué, Anna, Schmitz, Vanda Edit, Poleggi, Anna, Pocchiari, Maurizio, Sánchez-Valle, Raquel, Calero, Miguel, Calero, Olga, Baldeiras, Inês, Santana, Isabel, Kovacs, Gabor G., Llorens, Franc, Schmitz, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995564/ https://www.ncbi.nlm.nih.gov/pubmed/31795176 http://dx.doi.org/10.3390/biom9120800

Ejemplares similares

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
por: Schmitz, Matthias, et al.
Publicado: (2022)

Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2020)

Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients
por: Schmitz, Matthias, et al.
Publicado: (2016)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
por: Zerr, Inga, et al.
Publicado: (2020)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
por: Llorens, Franc, et al.
Publicado: (2020)

Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers
por: Hermann, Peter, et al.
Publicado: (2022)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
por: Kruse, Niels, et al.
Publicado: (2018)

Progress in CSF biomarker discovery in sCJD
por: Llorens, Franc, et al.
Publicado: (2016)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
por: Zerr, Inga, et al.
Publicado: (2021)

Genomic and post-genomic analyses of human prion diseases
por: Pocchiari, Maurizio, et al.
Publicado: (2009)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
por: Llorens, Franc, et al.
Publicado: (2017)

TREM2 expression in the brain and biological fluids in prion diseases
por: Diaz-Lucena, Daniela, et al.
Publicado: (2021)

The role of cellular prion protein in lipid metabolism in the liver
por: Arora, Amandeep Singh, et al.
Publicado: (2020)

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
por: Candelise, Niccolo, et al.
Publicado: (2020)

Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie
por: Schmitz, Matthias, et al.
Publicado: (2016)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
por: Emdina, Anna, et al.
Publicado: (2022)

Age at Death of Creutzfeldt-Jakob Disease in Subsequent Family Generation Carrying the E200K Mutation of the Prion Protein Gene
por: Pocchiari, Maurizio, et al.
Publicado: (2013)

Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis
por: Andrés-Benito, Pol, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
por: Ladogana, Anna, et al.
Publicado: (2009)

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives
por: Kanata, Eirini, et al.
Publicado: (2018)

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
por: Cramm, Maria, et al.
Publicado: (2014)

RNA editing alterations define manifestation of prion diseases
por: Kanata, Eirini, et al.
Publicado: (2019)

Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer’s Disease
por: Podlesniy, Petar, et al.
Publicado: (2020)

Prion2022-pushing the boundaries
por: Zerr, Inga
Publicado: (2023)

Altered mRNA and Protein Expression of Monocarboxylate Transporter MCT1 in the Cerebral Cortex and Cerebellum of Prion Protein Knockout Mice
por: Ramljak, Sanja, et al.
Publicado: (2021)

Cerebrospinal fluid real‐time quaking‐induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study
por: McGuire, Lynne I., et al.
Publicado: (2016)

Human prion diseases: progress in clinical trials
por: Zerr, Inga
Publicado: (2013)

Prion 2022 Conference abstracts: pushing the boundaries
por: Zerr, Inga
Publicado: (2022)

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018)

Prions and related neurological diseases
por: Pocchiari, Maurizio
Publicado: (1994)

BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
por: López-Pérez, Óscar, et al.
Publicado: (2020)

Yeast prions form infectious amyloid inclusion bodies in bacteria
por: Espargaró, Alba, et al.
Publicado: (2012)

The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases
por: Poleggi, Anna, et al.
Publicado: (2022)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
por: Stoeck, Katharina, et al.
Publicado: (2012)

Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein
por: Roettger, Yvonne, et al.
Publicado: (2013)

Differential interactome mapping of aggregation prone/prion-like proteins under stress: novel links to stress granule biology
por: Younas, Neelam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmu86v8ap6ge9hqkjahhp78bqt